Biosensors to Study Taspase1 Function and Identify Inhibitors
Author Information
Author(s): Shirley K. Knauer, Verena Fetz, Jens Rabenstein, Sandra Friedl, Bettina Hofmann, Samaneh Sabiani, Elisabeth Schröder, Lena Kunst, Eugen Proschak, Eckhard Thines, Thomas Kindler, Gisbert Schneider, Rolf Marschalek, Roland H. Stauber, Carolin Bier
Primary Institution: Institute for Molecular Biology, Centre for Medical Biotechnology (ZMB), University Duisburg-Essen, Essen, Germany
Hypothesis
Can efficient cell-based assays be developed to probe Taspase1 function and identify pharmacogenetic inhibitors?
Conclusion
The study presents a novel biosensor assay that allows for the identification of Taspase1 inhibitors and provides insights into Taspase1's biological function.
Supporting Evidence
- The biosensor assay allows for high-throughput screening of Taspase1 inhibitors.
- Two compounds were identified that partially inhibit Taspase1 cleavage in living cells.
- The assay was adapted for automated high-content data analysis.
Takeaway
Researchers created a special tool to see how a protein called Taspase1 works in cells, which could help find new medicines to stop cancer.
Methodology
The study used cell-based assays with biosensors to monitor Taspase1 activity and screen for inhibitors.
Limitations
The study's findings may be limited by the specificity of the biosensor and the potential for compound instability.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website